NCT01508494View on ClinicalTrials.gov

Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

June 29, 2011

Primary Completion Date

June 30, 2016

Study Completion Date

June 22, 2016

Conditions
StrokeCognitive Impairment
Interventions
DRUG

Galantamine

16 mg galantamine daily P/O

DRUG

placebo

placebo

Trial Locations (1)

31059

Service de Neurologie, CHU Toulouse Purpan, Toulouse

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT01508494 - Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment | Biotech Hunter | Biotech Hunter